The identification of high-performing antibodies for Sequestosome-1 for use in Western blot, immunoprecipitation and immunofluorescence

Sequestosome-1, encoded by the gene SQSTM1, functions as a bridge between ubiquitinated proteins and the proteasome or autophagosome, thereby regulating protein degradation pathways. Loss of Sequestosome-1 is hypothesized to enhance neurodegeneration progression in several diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal disorders (FTD). Sequestosome-1 reproducible research would be facilitated with the availability of well-characterized anti-Sequestosome-1 antibodies. In this study, we characterized seventeen Sequestosome-1 commercial antibodies for Western blot, immunoprecipitation, and immunofluorescence using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls. We identified many high-performing antibodies and encourage readers to use this report as a guide to select the most appropriate antibody for their specific needs.

[1]  P. McPherson,et al.  The identification of high-performing antibodies for TDP-43 for use in Western Blot, immunoprecipitation and immunofluorescence , 2023, F1000Research.

[2]  M. Martone,et al.  The Antibody Registry: ten years of registering antibodies , 2022, Nucleic Acids Res..

[3]  P. McPherson,et al.  Identification of highly specific antibodies for Serine/threonine-protein kinase TBK1 for use in immunoblot, immunoprecipitation and immunofluorescence , 2022, F1000Research.

[4]  S. Martens,et al.  Reconstitution defines the roles of p62, NBR1 and TAX1BP1 in ubiquitin condensate formation and autophagy initiation , 2021, Nature Communications.

[5]  E. Robert McDonald,et al.  Quantitative Proteomics of the Cancer Cell Line Encyclopedia , 2020, Cell.

[6]  Thomas M. Durcan,et al.  Implementation of an antibody characterization procedure and application to the major ALS/FTD disease gene C9ORF72 , 2019, eLife.

[7]  X. Xie,et al.  SQSTM1/p62: A Potential Target for Neurodegenerative Disease. , 2019, ACS chemical neuroscience.

[8]  Amos Bairoch,et al.  The Cellosaurus, a Cell-Line Knowledge Resource. , 2018, Journal of biomolecular techniques : JBT.

[9]  Damian Szklarczyk,et al.  Version 4.0 of PaxDb: Protein abundance data, integrated across model organisms, tissues, and cell‐lines , 2015, Proteomics.

[10]  M. Searle,et al.  SQSTM1 mutations--bridging Paget disease of bone and ALS/FTLD. , 2014, Experimental cell research.

[11]  J. Hardy,et al.  SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis. , 2013, JAMA neurology.

[12]  G. Bjørkøy,et al.  p62/SQSTM1 and ALFY interact to facilitate the formation of p62 bodies/ALIS and their degradation by autophagy , 2010, Autophagy.

[13]  G. Bjørkøy,et al.  p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death , 2005, The Journal of cell biology.